Physicians and clinicians have used clinical decision support (CDS) software for decades to inform decision making. Much of today’s CDS uses artificial intelligence (AI) algorithms and machine learning (ML) models to generate impressive recommendations and predictions. Are physicians at risk of becoming over-reliant on these tools?
That concern is one of the main topics discussed in the FDA issued guidance—now final—on regulating CDS software. In an article for Oatmeal Health, I give an overview of the guidance document and how it departs from draft guidances. I also share views from the medical device industry and provide takeaways for physicians—particularly those involved in developing CDS software. Give it a read, and please share your comments below or by sharing on your favorite social media channel. — Heather J.